NEOS THERAPEUTICS INC - COM (NEOS) Institutional Ownership

CUSIP: 64052L106

13F Institutional Holders and Ownership History from Q3 2015 to Q1 2021

Type / Class
Equity / COM
Symbol
NEOS
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 64052L106?
CUSIP 64052L106 identifies NEOS - NEOS THERAPEUTICS INC - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of NEOS THERAPEUTICS INC - COM (NEOS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2021 Q1 0 $0 -$6,444,995 0
2020 Q4 10,320,143 $6,447,006 -$3,371,543 $0.62 31
2020 Q3 16,490,318 $8,745,005 -$925,901 $0.53 33
2020 Q2 17,820,415 $12,209,178 -$1,120,830 $0.69 36
2020 Q1 19,450,968 $14,592,195 -$2,408,283 $0.75 43
2019 Q4 21,669,868 $32,712,135 +$1,767,703 $1.51 49
2019 Q3 20,528,289 $30,379,176 -$3,102,454 $1.48 47
2019 Q2 22,802,002 $29,401,126 -$11,077,662 $1.29 53
2019 Q1 27,280,721 $71,197,356 +$5,922,617 $2.61 59
2018 Q4 25,262,327 $41,681,901 +$12,737,682 $1.65 58
2018 Q3 13,398,895 $64,983,714 -$3,972,861 $4.85 67
2018 Q2 14,097,081 $88,068,075 -$11,047,264 $6.25 71
2018 Q1 15,305,028 $127,033,036 +$5,280,344 $8.30 75
2017 Q4 14,301,782 $145,648,071 +$11,700,069 $10.20 81
2017 Q3 13,262,903 $121,483,597 +$12,868,915 $9.15 61
2017 Q2 12,118,534 $88,460,841 +$22,556,288 $7.30 66
2017 Q1 9,028,252 $65,005,526 +$32,997,965 $7.20 49
2016 Q4 5,192,185 $30,406,031 -$2,479,233 $5.85 51
2016 Q3 5,511,366 $36,214,654 -$4,045,307 $6.58 46
2016 Q2 5,436,521 $50,450,499 -$7,749,482 $9.28 44
2016 Q1 6,225,796 $67,166,216 -$1,162,281 $10.79 45
2015 Q4 6,195,229 $88,378,117 -$4,696,044 $14.32 44
2015 Q3 6,128,023 $126,841,514 +$126,841,499 $21.01 41